Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Study: A brief sleep intervention can bring measurable and sustained benefits to children with ADHD

__

Sleep prob­lems are com­mon in chil­dren with ADHD, are more per­sis­tent than in the gen­er­al pop­u­la­tion, and often exac­er­bate dif­fi­cul­ties asso­ci­at­ed with ADHD. For exam­ple, poor sleep can enhance dif­fi­cul­ties with atten­tion and con­cen­tra­tion that most youth with ADHD expe­ri­ence.

Research has shown that brief sleep inter­ven­tions can improve sleep in youth with­out ADHD who expe­ri­ence sleep dif­fi­cul­ties. How­ev­er, Read the rest of this entry »

Large study finds positive yet mixed results from Akili’s digital therapeutic for kids with ADHD

__

Full pub­li­ca­tion of piv­otal tri­al data out­lines Akil­i’s case for FDA reg­u­la­tion (Mobi­Health­News):

A full tran­script of STARS-ADHD — the piv­otal tri­al of Akili Interactive’s video game-like pedi­atric atten­tion deficit treat­ment — has been pub­lished in The Lancet Dig­i­tal Health jour­nal, pro­vid­ing onlook­ers a clear view of data fuel­ing the dig­i­tal ther­a­peu­tic company’s pend­ing FDA sub­mis­sion Read the rest of this entry »

Study finds combined pharma + non-pharma treatment most beneficial to help youth with ADHD address long-term academic difficulties

__

Aca­d­e­m­ic dif­fi­cul­ties are one of the most impor­tant adverse con­se­quences of ADHD, and they fre­quent­ly con­tribute to par­ents’ deci­sion to seek treat­ment for their child. Whether treat­ment con­sis­tent­ly yields a pos­i­tive impact on long-term aca­d­e­m­ic suc­cess is thus an impor­tant issue; how­ev­er, the answer to this ques­tion has been some­what con­tro­ver­sial. Read the rest of this entry »

Will digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?

___

Akili Inter­ac­tive: Dig­i­tal pedi­atric ADHD ther­a­peu­tic per­forms well with or with­out accom­pa­ny­ing stim­u­lant ther­a­py (Mobi­Health News):

Dig­i­tal ther­a­peu­tic com­pa­ny Akili Inter­ac­tive has announced the first results of an open-label, mul­ti­site pedi­atric ADHD tri­al pro­vid­ing some patients with the company’s video game-like treat­ment along­side a stim­u­lant med­ica­tion.

Accord­ing to the com­pa­ny, both those who received the AKL-T01 ther­a­py with (n = 130) or with­out (n = 76) accom­pa­ny­ing stim­u­lant med­ica­tion saw sig­nif­i­cant improve­ments one month after Read the rest of this entry »

Study: Having ADHD costs $1.1 million in lower lifetime earnings, even when “treated”

___

Rel­a­tive­ly few stud­ies have exam­ined the impact of child­hood ADHD on long-term finan­cial out­comes, even though becom­ing self-sup­port­ing and attain­ing finan­cial inde­pen­dence is an impor­tant devel­op­men­tal task.

An espe­cial­ly com­pre­hen­sive look at this issue is pro­vid­ed in a study by Pel­ham et al pub­lished recent­ly in the Jour­nal of Con­sult­ing and Clin­i­cal Psy­chol­o­gy.

The Study:

Par­tic­i­pants were 364 adults who were diag­nosed with ADHD in child­hood along with 264 demo­graph­i­cal­ly matched con­trols. Read the rest of this entry »

Search in our Archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Watch All Recordings Now (40+ Speakers, 12+ Hours)